- Trials with a EudraCT protocol (7)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
7 result(s) found for: Repeated implantation failure.
Displaying page 1 of 1.
EudraCT Number: 2020-005893-93 | Sponsor Protocol Number: 00909043 | Start Date*: 2021-09-21 | |||||||||||
Sponsor Name:Uniwersytet Medyczny w Białymstoku | |||||||||||||
Full Title: A randomized, double-blind, placebo-controlled study evaluating levosimendan re-infusions in patients with severe heart failure with reduced left ventricular ejection fraction. | |||||||||||||
Medical condition: Ambulatory Heart Failure Patients | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: PL (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-003080-30 | Sponsor Protocol Number: CT2011-001 | Start Date*: 2011-07-26 | |||||||||||
Sponsor Name:ISTITUTO CLINICO HUMANITAS | |||||||||||||
Full Title: WEIGHT-ADJUSTED LOW MOLECOLAR WEIGHT HEPARIN IN RECURRENT IMPLANTATION FAILURE: A RANDOMIZED OPEN LABELED TRIAL | |||||||||||||
Medical condition: Infertile patients with at least three failed assisted reproductive tecniques | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-000595-33 | Sponsor Protocol Number: 2011-01-01REPEAT | Start Date*: 2013-04-25 |
Sponsor Name:Goethe University Frankfurt | ||
Full Title: Randomized controlled trial to compare the effects of single versus repeated intracoronary application of autologous bone marrow-derived mononuclear cells on total and SHFM-predicted mortality in p... | ||
Medical condition: Chronic post-infarction heart failure due to an at least 3 months old myocardial infarction, treated with optimal medication according to the evidence-based guidelines, in NYHA stadium II-III; and ... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Temporarily Halted) NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2019-002511-26 | Sponsor Protocol Number: 08062019 | Start Date*: 2019-12-20 | |||||||||||
Sponsor Name:Rigshospitalet | |||||||||||||
Full Title: Repeated Injection Therapy of Allogeneic Stem Cells in Ischemic No-option Patients - A Multi-Centre Study (SCIENCE REPEAT) | |||||||||||||
Medical condition: Ischemic heart failure | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-024328-53 | Sponsor Protocol Number: HULPOFT-2010-01 | Start Date*: 2012-05-14 |
Sponsor Name:Fundación para la Investigación Biomédica del Hospital Universitario La Paz | ||
Full Title: Phase IIa clinical trial to determine the feasibility and safety of using autologous expanded stem cell (ASC) from fat in the treatment of keratopathy associated with bilateral limbic insufficiency | ||
Medical condition: Keratopathy associated with bilateral limbic insufficiency. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Completed) | ||
Trial results: View results |
EudraCT Number: 2006-004608-37 | Sponsor Protocol Number: FER-CARS-02 | Start Date*: 2007-07-27 | |||||||||||
Sponsor Name:Vifor Pharma, Vifor (International) Ltd. | |||||||||||||
Full Title: A randomised double-blind controlled phase III study to compare the efficacy and safety of intravenous ferric carboxymaltose (Ferinject®) with placebo in patients with chronic heart failure and iro... | |||||||||||||
Medical condition: iron deficiency in patients with chronic heart failure | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) ES (Completed) IT (Completed) CZ (Completed) GR (Completed) SE (Completed) BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-003975-23 | Sponsor Protocol Number: IGX1-ENT-XS-16-01 | Start Date*: 2020-04-20 | |||||||||||
Sponsor Name:Asherman Therapy S.L.U. | |||||||||||||
Full Title: Efficacy and safety of autologous, mobilized, non-expanded CD133+ cells to treat Asherman´s Syndrome: A prospective, multi-center, phase I/II clinical trial. | |||||||||||||
Medical condition: Asherman's syndrome also known as intrauterine synechiae | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
